- Home
- SMID vs BDTX Comparison
SMID vs BDTX Comparison
Compare SMID & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMID
- BDTX
- Stock Information
- Founded
- SMID 1960
- BDTX 2014
- Country
- SMID United States
- BDTX United States
- Employees
- SMID N/A
- BDTX N/A
- Industry
- SMID Building Materials
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SMID Industrials
- BDTX Health Care
- Exchange
- SMID Nasdaq
- BDTX Nasdaq
- Market Cap
- SMID 166.5M
- BDTX 144.9M
- IPO Year
- SMID 1995
- BDTX 2020
- Fundamental
- Price
- SMID $40.95
- BDTX $2.20
- Analyst Decision
- SMID
- BDTX Strong Buy
- Analyst Count
- SMID 0
- BDTX 4
- Target Price
- SMID N/A
- BDTX $15.50
- AVG Volume (30 Days)
- SMID 20.2K
- BDTX 1.2M
- Earning Date
- SMID 11-14-2024
- BDTX 03-11-2025
- Dividend Yield
- SMID N/A
- BDTX N/A
- EPS Growth
- SMID 1025.92
- BDTX N/A
- EPS
- SMID 1.22
- BDTX N/A
- Revenue
- SMID $76,366,000.00
- BDTX N/A
- Revenue This Year
- SMID N/A
- BDTX N/A
- Revenue Next Year
- SMID N/A
- BDTX N/A
- P/E Ratio
- SMID $33.57
- BDTX N/A
- Revenue Growth
- SMID 32.40
- BDTX N/A
- 52 Week Low
- SMID $25.03
- BDTX $1.91
- 52 Week High
- SMID $51.96
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- SMID 44.35
- BDTX 46.41
- Support Level
- SMID $39.90
- BDTX $2.02
- Resistance Level
- SMID $40.20
- BDTX $2.33
- Average True Range (ATR)
- SMID 2.28
- BDTX 0.18
- MACD
- SMID -0.31
- BDTX 0.03
- Stochastic Oscillator
- SMID 32.70
- BDTX 38.16
About SMID Smith-Midland Corporation
Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.